Hydrogen Water Study for Parkinson's Disease Gets Data Correction
- Authors
- Asako Yoritaka, Takashi Abe, Chigumi Ohtsuka, Tetsuya Maeda, Masaaki Hirayama, Hirohisa Watanabe, Hidemoto Saiki, Genko Oyama, Jiro Fukae, Yasushi Shimo, Taku Hatano, Suihiro Kawajiri, Yasuyuki Okuma, Yutaka Machida, Hideto Miwa, Chikako Suzuki, Asuka Kazama, Masahiko Tomiyama, Takeshi Kihara, Motoyuki Hirasawa, Hideki Shimura, Nobutaka Hattori
- Journal
- BMC Neurology
- Year
- 2017
- DOI
- 10.1186/s12883-017-0817-2
- Study Type
- clinical
- Peer Reviewed
- Yes
- Country
- Japan
- Health Condition
- Parkinson's Disease
- Body System
- Nervous System
TL;DR
Researchers had to fix a small mistake in their study about whether a special type of water called hydrogen water could help people with Parkinson's disease—they counted the number of men and women wrong at first, but now it's corrected so the study information is accurate.
Key Finding
__no_content__
Summary
Scientists published a correction to a randomized double-blind multi-center clinical trial investigating hydrogen water therapy for Parkinson's disease. The erratum corrected participant demographics, showing 90 male and 88 female participants (178 total) rather than the originally reported 89 of each gender. This large-scale study is examining whether hydrogen water supplementation could provide therapeutic benefits for Parkinson's patients through its antioxidant and neuroprotective properties. The correction ensures accurate baseline characteristics for proper analysis of hydrogen water's potential efficacy in treating this progressive neurodegenerative disorder that affects movement and cognitive function.
Abstract
After publication of the original article [1], it came to the authors' attention that there was an error in the number of male and female participants. The correct number is 90 male and 88 female, not 89 male and 89 female as originally reported. This error was present in the Methods section of the abstract and in Table 1.